IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
Business Model:
Revenue: $3.9M
Employees: 11-50
Address: Arvid Wallgrens Backe 20
City: Gothenburg
State: västra götalands län
Zip: 413 46
Country: SE
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has identified, and is currently engaged in clinical development of, two novel compounds aimed at offering improved clinical benefit for patients with Parkinson’s disease.
Contact Phone:
Contact Email:
Listed Exchange:
Other
Ticker Symbol:
IRLAB-A
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Series A | 1 | $15.8M |
New Leaf Venture Partners New Leaf Venture Partners |
11/2018 | Grant | 1 | $81.4k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|